Valeant Shares Sinks on Longtime Bull's Downgrade

Updated on
  • BMO analyst downgrades stock, says questions have been raised
  • `Cannot defend the specialty pharmacy structure,' analyst says

Valeant Pharmaceuticals International Inc. shares plummeted for a second day after a BMO Capital Markets analyst who has advised buying the stock for more than two years downgraded the shares, citing questions about its close ties to pharmacies that distribute its drugs.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.